In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
about
Pairomics, the omics way to mate choiceOchronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinoneA universal system to select gene-modified hepatocytes in vivoThe ploidy conveyor of mature hepatocytes as a source of genetic variation.Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism.Mechanisms of liver injury relevant to pediatric hepatology.Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition.Aneuploidy as a mechanism for stress-induced liver adaptation.In vivo selection of transplanted hepatocytes by pharmacological inhibition of fumarylacetoacetate hydrolase in wild-type miceThe Caenorhabditis elegans K10C2.4 gene encodes a member of the fumarylacetoacetate hydrolase family: a Caenorhabditis elegans model of type I tyrosinemia.Slow-onset inhibition of fumarylacetoacetate hydrolase by phosphinate mimics of the tetrahedral intermediate: kinetics, crystal structure and pharmacokinetics.Disruption of fumarylacetoacetate hydrolase causes spontaneous cell death under short-day conditions in Arabidopsis.Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1.Assessing cell fusion and cytokinesis failure as mechanisms of clone 9 hepatocyte multinucleation in vitro.Homologous recombination mediates stable Fah gene integration and phenotypic correction in tyrosinaemia mouse-model.
P2860
Q26809970-510EA702-A145-4A02-804E-A184961D01BCQ28287543-575AACA8-9559-4BE9-85CA-6508647841B8Q28468539-08CE0869-22B6-4034-8C5F-33FD6CC744DCQ34259413-600B392D-9B49-4D9A-B73C-9F8A1C4BBBEDQ34283083-D944136E-9E2D-4AD3-AA96-27FF210AAB63Q34559789-4A7FAA44-C1F0-40CF-AD39-B20078C58C66Q36120348-2FE15981-709D-4610-9EB7-132CAD30A49CQ36190750-FDE52A8B-5C04-49A1-ACFE-6306C133386DQ36298651-0227C221-28B6-469E-857D-33A86976382DQ36727248-9DB40D7D-F857-4919-AC16-019138296F73Q40275851-12223478-F735-4701-B227-656E276501A3Q46184488-1FC40285-7EFB-4118-AB25-2A4DFF931E4AQ47134192-48E754F8-8AFB-4F4E-A263-A983019A56BDQ50492097-B1CA697B-AD18-4A6E-A4DD-24A9E8046A73Q54258264-A64A2E5B-A6DC-44F4-A4EB-CEDE1F294A31
P2860
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
@ast
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
@en
type
label
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
@ast
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
@en
prefLabel
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
@ast
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
@en
P2093
P2860
P356
P1476
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
@en
P2093
M Al-Dhalimy
M Finegold
P2860
P304
11928-11933
P356
10.1073/PNAS.96.21.11928
P407
P577
1999-10-01T00:00:00Z